The following data is part of a premarket notification filed by Abbott Laboratories with the FDA for Modification To Precision Xtra Advanced Diabetes Management System.
Device ID | K040814 |
510k Number | K040814 |
Device Name: | MODIFICATION TO PRECISION XTRA ADVANCED DIABETES MANAGEMENT SYSTEM |
Classification | System, Test, Blood Glucose, Over The Counter |
Applicant | ABBOTT LABORATORIES 4-A CROSBY DR. Bedford, MA 01730 -1402 |
Contact | Tracey H Wielinski |
Correspondent | Tracey H Wielinski ABBOTT LABORATORIES 4-A CROSBY DR. Bedford, MA 01730 -1402 |
Product Code | NBW |
Subsequent Product Code | JIN |
Subsequent Product Code | LFR |
CFR Regulation Number | 862.1345 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Special |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2004-03-30 |
Decision Date | 2004-04-15 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
30093815998373 | K040814 | 000 |
30093815988145 | K040814 | 000 |
30093815715024 | K040814 | 000 |